Table 1.
Demographic and risk data for study participants
| Characteristics | (N = 63) |
|---|---|
| Recruitment | |
| Duke University | 34 |
| Ohio State University (OSU) | 21 |
| Roswell Park Cancer Institute (RPCI) | 6 |
| Dana Farber Cancer Institute (DFCI) | 1 |
| University of Vermont (UV) | 1 |
| Mean age in y (range) | 45.3 (36–55) |
| Menopausal status | |
| Postmenopausal | 8 (13%) |
| Pre/Perimenopausal | 55 (87%) |
| Race | |
| Caucasian | 59 (94%) |
| African American | 2 (3%) |
| Hispanic | 2 (3%) |
| Body mass index in kg/m2 (range) | 25.3 (17.9–36.3) |
| Average 5-y Gail model risk score (range) | 3.2 (0.6–12.9) |
| Known or suspected BRCA1/2 mutation carrier (total) | 11 (17%) |